Clinical Transformation Study of Guben Qushi Huayu Formula for Treatment of Mild-Moderate Ulcerative Colitis

The Second Affiliated Hospital of Guangzhou University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Cases that meet the clinical diagnosis and definitive diagnosis of Western diagnostic criteria;
•2. Meets the criteria for ulcerative colitis in mild to moderate active periods;
•3. Diagnostic criteria for spleen deficiency and dampness syndrome in line with expert consensus;
•4. Signed informed consent, good compliance, and follow-up;
•5. Outpatient or hospitalized patients aged 18 to 70 years;
•6. Do not use drugs or other treatments that affect the evaluation of efficacy during treatment.

•1. Lactation, pregnant women, and patients intolerant to this drug;
•2. Severe primary disease such as severe heart, lung, liver, kidney and hematopoietic system, mental patients;
•3. Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease;
•4. Persons with disabilities prescribed by law (dumb, sputum, blindness, mental disorder, physical disability, mental retardation).

发起方

The Second Affiliated Hospital of Guangzhou University of TCM